Anjan Chakrabarti

Anjan holds a Ph.D. in Organic Chemistry from the Indian Institute of Chemical Technology, Hyderabad and has completed post-doctoral work at GlaxoSmithKline (GSK), Collegeville, PA, USA which was funded by NIH. Anjan has completed his Executive Program in Management from the University of California at Berkeley’s Haas School of Business. He has over 20 year of global experience in drug discovery and been associated with organisations like Affymax and Albany Molecular Research Inc., (AMRI). Anjan has experience in several therapeutic areas – hematology, oncology, antibacterial, anti-HIV, CNS & anti-inflammatory. He has more than 25 patents & publications to his credit. Prior to joining Syngene, Anjan was a Senior Director and Head of AMRI’s Singapore Research operation and lead AMRI’s drug discovery research efforts in Asia with cross-functional teams in India and Singapore. At Syngene he is responsible for leading over 800 scientists engaged in drug discovery in the Discovery Chemistry Group. The team consists of medicinal chemists, analytical and CADD scientists engaged in drug discovery projects in multiple therapeutic areas. He is also involved in defining the business development and marketing strategy for discovery chemistry and integrated drug discovery.